Big Catalysts to come : FDA180 days Device and 365 days while $Dexcom is 7 to 9 days.
Extremely undervalued Diabetes company.
Stocks to be much more Expendable, much more Bombing, much more Explosive and much more Lucrative for investment.
Compare the market cap between $SENS and $DXCM : $1.273B vs $38.26B.
$SENS to overwhelm $DXCM in 2(two) years because of "Unprecedented and Unique Diabetes management systems and its demonstrated and proven #1 quality levels of Accuracy.
Big Institutions by about 140 ea to back up $SENS strongly : Gilder Gagnon Howe & Co Llc, NEA Management Company, LLC, Delphi Management Partners VIII, L.L.C., Vanguard Group Inc, VTSMX - Vanguard Total Stock Market Index Fund Investor Shares, BlackRock Inc., VEXMX - Vanguard Extended Market Index Fund Investor Shares, Masters Capital Management Llc, Pura Vida Investments, Llc, and Millennium Management Llc, and George Soros Fund Management WHICH is one of Legendary Hedge funds investors!
Cost covered by Aetna, BlueCross/BlueShield, blue California, Horizon NJ Health, TRICARE, U.S. Department of Veterans Affairs, HCSC, Humana, hmsa, Cigna, AmeriHealth, HIGHMARK, MOLINA HEALTHCARE, CareFirst Premera, Independence, and Medicare.
@gazenhauser I bought it pretty much randomly when I saw it featured on trading212 "winners today" the day it jumped to 1.10$ and got interested in it (haven't heard about it before)
Little did I know how well this stock would perform in the coming weeks . I like the technology, though it seems the market cap is getting ahead of itself
@gazenhauser I've heard about them through my specialist on routine check up. Their biggest hurdle is going to be convincing people it's worth scheduling outpatient procedures to implant and remove. The MARD is similar to worse then the Dexcom 6 over the duration of implantation so I don't see where the more accurate then and proven #1 accuracy comes from.
@butterflyaway I'm in Europe in country where telemedicine is not really a thing. Still, I have not seen my doctor in person for 13 months, as he is over 80. We have scheduled appointments every 3 months.
I'm using Dexcom, so he can check my bg values remotely, he can write recipes online. I had my blood tests a month ago (I skipped one, usually we have it every 6 months).
@butterflyaway It's not allowed to be implanted by any doctors at the specialist office. So therefore, have to schedule an outpatient procedure with a general physician.
@gazenhauser As a type 1 myself, I like the idea of a long lasting CGM. Currently my Dexcom G6 lasts 8-10 days. They advertise that it can go 10 days but when it gets closer to 10 days it can start having some issues once in awhile. The outpatient procedure is pretty minimal, I’ve seen the videos on YouTube. They numb your arm, cut into it a little bit and implant the device. Devices that are implanted into the body for medical purposes are becoming more and more popular and I don’t know many diabetics who would care to get a minimally invasive surgery done if it meant they could have a CGM last 180-365 days. My only concerns are 1. They need frequent blood glucose finger stick calibrations 2. The battery for the device that goes over the sensor apparently drains quick. If they could find a way to calibrate 1x a week and have the device that goes over the sensor last at least a week without being charged I think that would be great. Diabetics care about convenience and accuracy. I’m not sure about the claim on being the most accurate? I know this was true when their 90 day was compared to the Dexcom G5 but haven’t heard much about the comparison to the G6. I’ve heard some endocrinologist say that this has potential to be a game changer. I only have a small position of 60 shares but I like the idea of what the company is doing.
@resjudicata I’ve been using the eversense for over a year now. Finger sticks twice a day are annoying but to me it’s worth it. I could never get the dexcom or Libre to stay on (even with skintac and sim patch). I haven’t invested in $SENS yet because of the negative perception of the eversense from endocrinologists. Even though the procedure is easy and quick operating isn’t their specialty.
@resjudicata G5 and G6 have very similar MARD, the big feat of G6 is that it does that without requiring any calibration, so less probability of user error.
My personal experience is that the G6 feels a bit quicker to react on bg changes.
@gazenhauser I’m balls deep in SENS - i think proprietary tech within a space like Diabetic treatment opens up huge growth possibility. Would love to see them become an industry disruptor, I’ve seen a lot of that sentiment from my research on their products
@youngwife I'm weary of proprietary tech. From an investor perspective it might look good, but not so much from a consumer point of view (though most people probably don't think about this).
I believe the future of diabetes tech is artificial pancreas; if I had diabetes I'd surely be interested in such a device (they are already being tested and I even knew some people in trials). However, I'd also be quite worried about putting a proprietary device in my body, that has closed-source code that cannot be openly inspected, and could possibly have undiscovered security exploits that could legitimately be dangerous.
@gazenhauser What do the explanted sensors look like? Dexcom pivoted away from a long term implantable in 2006 primarily because the explanted sensors occasionally took out golf ball-sized chunks of tissue with them, due to the promotion of vascularized tissue needed to get meaningful glucose readings.
Why did you not mention that DXCM is factory-calibrated where the SENS requires 2 daily fingerstick readings in order to verify calibration? If the incentive is for the patient to not have to poke themselves, then a long-term sensor that requires 2 daily finger pricks is an inferior user experience to a short term sensor that requires no finger pricks.
“I installed my first G6 sensor 2 days ago, I was fasting and xDrip in native mode showed a reading 30 mg/dl higher than my fingersticks. I waited a couple of hours after warmup and tried again, it was still high so I calibrated it with a fingerstick reading, within an hour it was still 20-30 pts too high. A few hours after I broke my fast last night and again this morning I did some more fingersticks and found it was high by as much as 55 points. I have added 3 more calibrations over the past 5 hours when my glucose was stable and it seems to be getting more accurate.”
@gazenhauser Literally did not even attempt to answer my questions, instead choosing to show one example of a user who had challenges after deciding to deviate from the factory calibration code for unknown reasons.
. I like the technology, though it seems the market cap is getting ahead of itself